Gene therapy in osteoarticular diseases: Where are we?

Abstract

Elucidation of the molecular and cellular basis of joint destruction in rheumatoid arthritis is revealing novel targets for gene transfer therapy of this disease. A recent meeting evaluated progress in gene delivery systems and discussed future strategies.